mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.08 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.08 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.1 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |